(Q43129374)

14 November 2017

title

CD40 ligand shedding is regulated by interaction between matrix metalloproteinase-2 and platelet integrin alpha(IIb)beta(3). (English)

1 reference

14 November 2017

W-S Choi

1

1 reference

14 November 2017

O-H Jeon

series ordinal

2

1 reference

14 November 2017

D-S Kim

series ordinal

3

1 reference

14 November 2017

publication date

3 March 2010

1 reference

Journal of Thrombosis and Haemostasis

14 November 2017

published in

1 reference

14 November 2017

volume

8

1 reference

14 November 2017

issue

6

1 reference

14 November 2017

page(s)

1364-1371

1 reference

Molecular and biological characterization of a murine ligand for CD40

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Human native soluble CD40L is a biologically active trimer, processed inside microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

CD40 ligand: a novel target in the fight against cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Increased circulating matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

AlphaIIbbeta3 priming and clustering by orally active and intravenous integrin antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

RGD-ligand mimetic antagonists of integrin alphaIIbbeta3 paradoxically enhance GPVI-induced human platelet activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Membrane protein secretases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Soluble CD40 Ligand in Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

Release of gelatinase A during platelet activation mediates aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03837.X

10.1111/J.1538-7836.2010.03837.X

21 January 2018

Identifiers

DOI

1 reference

14 November 2017

1 reference